Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-03 2:02 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | Nantahala Capital Management LLC | 1,962,070 15.1% | 1,962,070 (New Position) | View |
| 2024-06-18 4:30 pm Unchanged | 13D | AYTU BIOPHARMA INC AYTU | Nantahala Capital Management LLC | 1,086,812 18.2% | 0 (Unchanged) | View |
| 2024-03-11 4:06 pm Purchase | 13G | Rezolute Inc. RZLT | Nantahala Capital Management LLC | 4,118,164 9.9% | 4,118,164 (New Position) | View |
| 2024-02-14 4:51 pm Sale | 13G | RMR GROUP INC RMR | Nantahala Capital Management LLC | 404,063 2.6% | -554,211 (-57.83%) | View |
| 2024-02-14 4:51 pm Sale | 13G | VIEMED HEALTHCARE IN VMD | Nantahala Capital Management LLC | 1,952,368 5.1% | -845,220 (-30.21%) | View |
| 2024-02-14 4:51 pm Sale | 13G | Cidara Therapeutics Inc. CDTX | Nantahala Capital Management LLC | 1,546,745 1.7% | -2,820,719 (-64.58%) | View |
| 2024-02-14 4:51 pm Sale | 13G | Fortress Biotech Inc. FBIO | Nantahala Capital Management LLC | 372,562 4.2% | -7,595,494 (-95.32%) | View |
| 2024-02-14 4:51 pm Sale | 13G | IMAX CORP IMAX | Nantahala Capital Management LLC | 2,658,753 4.9% | -2,329,436 (-46.70%) | View |
| 2024-02-14 4:51 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | Nantahala Capital Management LLC | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:51 pm Purchase | 13G | Bioventus Inc. BVS | Nantahala Capital Management LLC | 5,977,471 9.5% | 5,977,471 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | CODEXIS INC. CDXS | Nantahala Capital Management LLC | 4,592,903 6.6% | 105,121 (+2.34%) | View |
| 2024-02-14 4:51 pm Sale | 13G | DHI GROUP INC. DHX | Nantahala Capital Management LLC | 2,639,687 5.6% | -1,022,289 (-27.92%) | View |
| 2024-02-14 4:51 pm Sale | 13G | LUXFER HOLDINGS PLC LXFR | Nantahala Capital Management LLC | 1,809,645 6.7% | -642,674 (-26.21%) | View |
| 2024-02-14 4:51 pm Sale | 13G | RED VIOLET INC RDVT | Nantahala Capital Management LLC | 1,205,678 8.6% | -69,410 (-5.44%) | View |
| 2024-02-14 4:51 pm Sale | 13G | STRATA Skin Sciences Inc. SSKN | Nantahala Capital Management LLC | 3,128,132 8.9% | -1,265,553 (-28.80%) | View |
| 2024-02-14 4:51 pm Sale | 13G | uniQure N.V. QURE | Nantahala Capital Management LLC | 3,158,027 6.6% | -729,912 (-18.77%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | Assertio Holdings Inc. ASRT | Nantahala Capital Management LLC | 7,619,440 8% | 7,619,440 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | Evolus Inc. EOLS | Nantahala Capital Management LLC | 2,910,849 5.1% | 2,910,849 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | GAIA INC GAIA | Nantahala Capital Management LLC | 915,029 5.2% | 915,029 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC | Nantahala Capital Management LLC | 1,214,094 5.1% | 1,214,094 (New Position) | View |